Benign Prostatic Hyperplasia (BPH)

Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate. The most clinical manifestation of BPH is lower urinary tract symptoms, including those associated with obstruction/voiding and those associated with irritation, storage, and filling. BPH is a disease of the aging male population with a dramatic increase in incidence after the age of 50 years. The American Urological Association estimates that BPH will affect approximately 50 percent of men between the ages of 51 and 60 and up to 90 percent of men over the age of 80.

Preclinical animal studies of Litx in BPH were concluded in mid-2007, and two Phase I studies in patients with BPH are underway. The Litx device used in BPH is incorporated into a single-use, disposable foley catheter, providing a simple, easy-to-use 42-minute treatment.